Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.25.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
REVENUES $ 721 $ 726
COST OF REVENUES 470 506
GROSS PROFIT 251 220
OPERATING EXPENSES:    
Research and development expenses 681 647
Sales and marketing expenses 666 627
General and administrative expenses 716 817
TOTAL OPERATING EXPENSES 2,063 2,091
OPERATING LOSS (1,812) (1,871)
Interest expense (34) (207)
Other Financial income (expense), net (14) 92
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,860) $ (1,986)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.22) $ (0.5)
Net loss per share attributable to common shareholders – diluted (in Dollars per share) $ (0.22) $ (0.5)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 8,520,110 3,978,828
Weighted average number of common stocks used in computing net loss per share – diluted (in Shares) 8,520,110 3,978,828